Geode Capital Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Geode Capital Management’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-13,679	Closed	-$150K	–	4203
2015 Q4	$150K	Buy	+13,679	New	+$151K	﹤0.01%	3780
2015 Q3	–	Sell	-9,545	Closed	-$36K	–	4211
2015 Q2	$36K	Hold	9,545	–	–	﹤0.01%	3899
2015 Q1	$37K	Hold	9,545	–	–	﹤0.01%	3879
2014 Q4	$132K	Hold	9,545	–	–	﹤0.01%	3722
2014 Q3	$118K	Hold	9,545	–	–	﹤0.01%	3720
2014 Q2	$174K	Sell	9,545 -814	-8%	-$13.9K	﹤0.01%	3555
2014 Q1	$224K	Hold	10,359	–	–	﹤0.01%	3462
2013 Q4	$366K	Buy	+10,359	New	+$347K	﹤0.01%	3211

Other funds holding KBIO

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geode Capital Management's KBIO Position: Q1 2016 in Review

Geode Capital Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 13,679 shares — an estimated $150K sold.

Geode Capital Management first reported a position in KBIO in Q4 2013 and held it in 8 quarters. The position peaked at $366K in Q4 2013. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

Geode Capital Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
Geode Capital Management sold 13,679 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $150K.
Geode Capital Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q4 2013 and held it in 8 quarters.
Geode Capital Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $366K in Q4 2013.
1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Geode Capital Management's 13F filing for Q1 2016, filed 13 May 2016.